Meet Neuroservices-Alliance at Neuroscience 2024 at Booth #459.
Breakthroughs in electrophysiology, cellular models, and innovative drug discovery methods are transforming neuroscience and pain research. Neuroservices-Alliance is committed to pushing these advancements further by offering comprehensive preclinical services, from in vitro and in vivo models to specialized electrophysiological recordings.
Our deep expertise in CNS research enables us to provide meaningful data that help clients accelerate drug discovery and development.
We are proud to present our latest research on NGN2-induced neurons at SfN 2024, focusing on their application in preclinical drug discovery. This study explores the electrophysiological properties of NGN2-induced neurons and their potential use in CNS drug research, particularly for neurodegenerative and neuropsychiatric conditions.
Our poster highlights the validation and utility of this human iPSC-derived model for understanding neuronal activity and screening potential therapeutic compounds.
Electrophysiological Characterization of NGN2-Induced Neurons for CNS Drug Discovery
📅 Session PSTR009.22: Intrinsic Properties: Diversity and Function
🗓 Date: October 5, 2024
🕐 Time: 1:00 PM – 5:00 PM
📍 Location: Poster Session PSTR009.22 / B93
🔎 Read abstract: https://lnkd.in/gDbrYN44
Our leadership and scientific experts will be on-site and ready to discuss how our services can support your research. Don’t miss the opportunity to connect with our team:
Olivier Toury
Co-founder, CEO
Regina Valades
Business Development Manager
Diane Royer
Head of Marketing Communications
Bob Petroski, PhD
CSO, In Vitro Cell electrophysiology
Julien Allard, PhD
CSO, In Vivo Spinal Cord & DRG Electrophysiology
Want to learn more about our offer:
To consult our past publications and posters, visit our page On-demand resources.
